Opinion

Video

Chronic Myeloid Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

Author(s):

Elias Jabbour, MDJames M. Foran, MD

Expert perspectives on key data in chronic myeloid leukemia from the ASCO 2023 and EHA 2023 Annual Meetings.

Related Videos
Ben Levy, MD, and Yan Leyfman, MD
BTK Inhibitors in CLL : Second Generation Drugs and Beyond
Carrie L. Kitko, MD
Lori A. Leslie, MD
Lori A. Leslie, MD
Changchun Deng, MD, PhD
Guenther Koehne, MD, PhD
Ibrahim Aldoss, MD
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University
Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Related Content
Peter Borchmann, MD, of University Hospital of Cologne
June 1st 2024

BrECADD Regimen Improves PFS vs eBEACOPP Regimen in Advanced Classical Hodgkin Lymphoma

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

Jorge E. Cortes, MD, of Georgia Cancer Center at Augusta University
May 31st 2024

Asciminib Bests Standard-of-Care TKIs in Ph+ CML

Matthew Lunning, DO, FACP
November 30th 2023

Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma

Craig Eckfeldt, MD, PhD, of the University of Minnesota
May 22nd 2024

Eckfeldt Looks Towards the Future of AML and MDS Care

Carrie L. Kitko, MD
May 22nd 2024

CAR T-Cell Therapies Move Ahead in Pediatric and Adult ALL